ID
33729
Beschrijving
A Randomised Trial Evaluating Continuous Subcutaneous Infusion of Formulations of NN1218 and NovoLog® in Subjects With Type 1 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01682902
Link
https://clinicaltrials.gov/show/NCT01682902
Trefwoorden
Versies (1)
- 21-12-18 21-12-18 -
Houder van rechten
See clinicaltrials.gov
Geüploaded op
21 december 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Diabetes NCT01682902
Eligibility Diabetes NCT01682902
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
Diabetic Ketoacidosis Episodes Hospitalization Required
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0011880
- UMLS CUI [1,2]
- C0332189
- UMLS CUI [1,3]
- C1708385
Beschrijving
Infusion site abscess
Datatype
boolean
Alias
- UMLS CUI [1]
- C1142012
Beschrijving
Loss of hypoglycemic warning | Hypoglycaemic episodes Severe Hospitalization Required
Datatype
boolean
Alias
- UMLS CUI [1]
- C0342317
- UMLS CUI [2,1]
- C0745153
- UMLS CUI [2,2]
- C0205082
- UMLS CUI [2,3]
- C1708385
Similar models
Eligibility Diabetes NCT01682902
- StudyEvent: Eligibility
C0872146 (UMLS CUI [1,2])
C0393124 (UMLS CUI [2])
C0205369 (UMLS CUI [1,2])
C0332189 (UMLS CUI [1,2])
C1708385 (UMLS CUI [1,3])
C0745153 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C1708385 (UMLS CUI [2,3])